Susquehanna International Group
KRTX

Susquehanna International Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Susquehanna International Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,118
Closed -$12.1M – 13733
2023
Q4 		$12.1M Buy
38,118
+10,575
+38% +$2.06M ﹤0.01% 2402
2023
Q3 		$4.66M Sell
27,543
-78,240
-74% -$14.7M ﹤0.01% 3658
2023
Q2 		$22.9M Buy
105,783
+60,487
+134% +$13M ﹤0.01% 1594
2023
Q1 		$8.23M Buy
45,296
+30,655
+209% +$5.86M ﹤0.01% 2731
2022
Q4 		$2.88M Sell
14,641
-4,271
-23% -$916K ﹤0.01% 4084
2022
Q3 		$4.25M Buy
18,912
+14,650
+344% +$2.97M ﹤0.01% 3417
2022
Q2 		$539K Sell
4,262
-8,908
-68% -$1.02M ﹤0.01% 8082
2022
Q1 		$1.67M Sell
13,170
-6,863
-34% -$773K ﹤0.01% 5877
2021
Q4 		$2.62M Buy
20,033
+4,223
+27% +$546K ﹤0.01% 4902
2021
Q3 		$1.93M Sell
15,810
-7,473
-32% -$863K ﹤0.01% 5914
2021
Q2 		$2.65M Sell
23,283
-8,047
-26% -$941K ﹤0.01% 5297
2021
Q1 		$3.77M Sell
31,330
-4,853
-13% -$550K ﹤0.01% 4473
2020
Q4 		$3.68M Buy
36,183
+15,923
+79% +$1.48M ﹤0.01% 3957
2020
Q3 		$1.57M Sell
20,260
-1,999
-9% -$170K ﹤0.01% 5095
2020
Q2 		$2.48M Buy
22,259
+7,902
+55% +$687K ﹤0.01% 4113
2020
Q1 		$1.03M Buy
+14,357
New +$1.23M ﹤0.01% 5331

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Susquehanna International Group's KRTX Position: Q1 2024 in Review

Susquehanna International Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 38,118 shares — an estimated $12.1M sold.

Susquehanna International Group first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $22.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Susquehanna International Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 38,118 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $12.1M.
  • Susquehanna International Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Susquehanna International Group's Karuna Therapeutics, Inc. Common Stock position peaked at $22.9M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.